Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genetic Lingo01:11

Genetic Lingo

84.0K
Overview
84.0K
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

7.8K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
7.8K
Gene Therapy00:59

Gene Therapy

22.0K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
22.0K
Gene Therapy00:59

Gene Therapy

4.3K
4.3K
Maxam-Gilbert Sequencing01:05

Maxam-Gilbert Sequencing

10.3K
In the same year as the discovery of the Sanger sequencing method, another group of scientists, Allan Maxam and Walter Gilbert, demonstrated their chemical-cleavage method for DNA sequencing. The Maxam-Gilbert method relies on using different chemicals that can cleave the DNA sequence at specific sites, the separation of resulting DNA fragments of variable size using electrophoresis, and deciphering the DNA sequence from the resulting gel bands.
Challenges of the Maxam-Gilbert Method
The...
10.3K
Genetic Screens02:46

Genetic Screens

4.6K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
4.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Leveraging optimized oligonucleotide-tagged antigen assemblies and single-cell sequencing for multiplexed proteogenomic profiling of human B cell reactivities.

Journal of immunology (Baltimore, Md. : 1950)·2025
Same author

SARS-CoV-2 IgG Spike antibody levels and avidity in natural infection or following vaccination with mRNA-1273 or BNT162b2 vaccines.

Human vaccines & immunotherapeutics·2023
Same author

Assay Harmonization Study To Measure Immune Response to SARS-CoV-2 Infection and Vaccines: a Serology Methods Study.

Microbiology spectrum·2023
Same author

A Trans-Governmental Collaboration to Independently Evaluate SARS-CoV-2 Serology Assays.

Microbiology spectrum·2022
Same author

TIPICO XI: report of the first series and podcast on infectious diseases and vaccines (aTIPICO).

Human vaccines & immunotherapeutics·2021
Same author

Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in All of Us Research Program Participants, 2 January to 18 March 2020.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2021

Related Experiment Video

Updated: Apr 23, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

9.2K

Decoding gene patents in Australia.

Adam Denley1, James Cherry1

  • 1Freehills Patent Attorneys, Melbourne, Victoria 3000, Australia.

Cold Spring Harbor Perspectives in Medicine
|October 5, 2014
PubMed
Summary
This summary is machine-generated.

Gene patenting in Australia allows for isolated DNA and RNA. This review examines Australian legal decisions on patenting naturally occurring genetic material.

More Related Videos

Clonogenic Assay: Adherent Cells
05:30

Clonogenic Assay: Adherent Cells

Published on: March 13, 2011

48.6K
A Web-Based Workflow for Selecting Gene- and Tissue-Specific Enhancers
08:12

A Web-Based Workflow for Selecting Gene- and Tissue-Specific Enhancers

Published on: July 18, 2025

791

Related Experiment Videos

Last Updated: Apr 23, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

9.2K
Clonogenic Assay: Adherent Cells
05:30

Clonogenic Assay: Adherent Cells

Published on: March 13, 2011

48.6K
A Web-Based Workflow for Selecting Gene- and Tissue-Specific Enhancers
08:12

A Web-Based Workflow for Selecting Gene- and Tissue-Specific Enhancers

Published on: July 18, 2025

791

Area of Science:

  • Biotechnology Law
  • Intellectual Property Rights
  • Molecular Biology

Background:

  • Patents for naturally occurring genetic material (DNA, RNA, genes) have been historically granted in Australia.
  • The patentability of isolated genetic material remains a contentious issue globally and within Australia.

Purpose of the Study:

  • To review the gene patent debate in Australia.
  • To analyze how Australian legal systems have addressed the patent eligibility of genetic material.

Main Methods:

  • Review of Australian Patent Office decisions.
  • Analysis of Australian court rulings.
  • Examination of government policy and legislation related to gene patents.

Main Results:

  • The Australian legal system has grappled with defining patentable subject matter for genetic material.
  • Decisions reflect evolving interpretations of patent law in the context of biotechnology.

Conclusions:

  • The patentability of isolated genetic material in Australia has been subject to significant legal scrutiny.
  • Understanding these legal precedents is crucial for researchers and companies in the biotechnology sector.